Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeiger Counter Regulatory News (GCL)

Share Price Information for Geiger Counter (GCL)

Share Price is delayed by 15 minutes
Get Live Data
72.80    0.20 (0.28%)
Bid:
71.00
Ask:
74.60
Spread: 3.60 (5.07%)
Market Cap: £91.58m
GCL Live PriceLast checked at - London Stock Exchange

Intraday Geiger Counter Share Chart

Annual Overview from QuotedData

10 Jul 2025 14:48

RNS Number : 6102Q
Geiger Counter Ltd
10 July 2025
 

Geiger Counter Limited - Annual Overview from QuotedData

10th July 2025

Enriched prospects

A commitment to quadruple nuclear generating capacity in the US, made by President Donald Trump in a series of executive orders signed at the end of May, has provided a significant and much-needed boost to the uranium sector, in which Geiger Counter (GCL) invests. A number of uranium stocks rose by double figures in the days following the pledge to "re-establish the US as a global leader in nuclear energy".

Investor sentiment towards the sector had been waning prior to this, with a number of factors combining to put downward pressure on GCL's net asset value (NAV) (which we explore on page 4). In reality, this was in stark contrast to the fundamentals of the uranium market, which is displaying both demand-side expansion (increasing energy needs, especially from countries seeking lower-emission baseload power) and supply-side constraints. The expertise and long-term track record of GCL's manager, along with the extremely positive market fundamentals, make it an opportune time to invest in the company.

Full Research:

https://quoteddata.com/research/geiger-counter-limited-enriched-prospects-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Geiger Counter Limited, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEADXEFLKSEFA
Date   Source Headline
10th Apr 202612:28 pmRNSNotification Shareholders - Subscription Rights
9th Apr 20262:18 pmRNSNet Asset Value(s)
8th Apr 20262:50 pmRNSNet Asset Value(s)
1st Apr 20262:52 pmRNSNet Asset Value(s)
31st Mar 20264:19 pmRNSNet Asset Value(s)
30th Mar 20264:40 pmRNSNotification in regards to subscription rights
30th Mar 20262:44 pmRNSNet Asset Value(s)
27th Mar 20263:28 pmRNSNet Asset Value(s)
26th Mar 20264:39 pmRNSUpdate Regarding Resignation of Portfolio Managers
26th Mar 20263:15 pmRNSNet Asset Value(s)
25th Mar 20262:19 pmRNSNet Asset Value(s)
24th Mar 20264:30 pmRNSNet Asset Value(s)
23rd Mar 20263:23 pmRNSNet Asset Value(s)
20th Mar 20262:34 pmRNSNet Asset Value(s)
19th Mar 20263:38 pmRNSNet Asset Value(s)
18th Mar 20263:59 pmRNSNet Asset Value(s)
17th Mar 20264:02 pmRNSNet Asset Value(s)
16th Mar 20264:36 pmRNSProtective notice issued to investment manager
16th Mar 20263:07 pmRNSNet Asset Value(s)
12th Mar 20269:02 amRNSGovernance Changes
12th Mar 20269:02 amRNSGovernance Changes
11th Mar 20263:58 pmRNSResults of AGM
11th Mar 20263:58 pmRNSResults of AGM
9th Mar 20262:50 pmRNSNet Asset Value(s)
9th Mar 202610:00 amRNSResignation of Portfolio Managers - Replacement
9th Mar 20269:00 amRNSResignation of Portfolio Managers
6th Mar 20262:30 pmRNSNet Asset Value(s)
5th Mar 20262:51 pmRNSNet Asset Value(s)
4th Mar 20262:49 pmRNSNet Asset Value(s)
3rd Mar 20263:59 pmRNSNet Asset Value(s)
2nd Mar 20262:45 pmRNSNet Asset Value(s)
27th Feb 202612:53 pmRNSNet Asset Value(s)
26th Feb 20263:29 pmRNSNet Asset Value(s)
25th Feb 20263:05 pmRNSNet Asset Value(s)
24th Feb 20263:05 pmRNSNet Asset Value(s)
23rd Feb 20261:35 pmRNSNet Asset Value(s)
20th Feb 20263:32 pmRNSNet Asset Value(s)
20th Feb 202610:44 amRNSMonthly Factsheet- January 2026
19th Feb 20262:38 pmRNSNet Asset Value(s)
18th Feb 20261:50 pmRNSNet Asset Value(s)
17th Feb 20264:31 pmRNSNet Asset Value(s)
16th Feb 20263:48 pmRNSNet Asset Value(s)
16th Feb 20267:00 amRNS-RKepler Trust Intelligence: New Research
13th Feb 20263:10 pmRNSNet Asset Value(s)
12th Feb 20263:08 pmRNSNet Asset Value(s)
11th Feb 20264:24 pmRNSNet Asset Value(s)
10th Feb 20263:30 pmRNSNet Asset Value(s)
9th Feb 20263:17 pmRNSNet Asset Value(s)
6th Feb 20262:43 pmRNSNet Asset Value(s)
5th Feb 20261:20 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.